Idexx Laboratories (IDXX) Invested Capital (2009 - 2026)

Idexx Laboratories has reported Invested Capital for 18 years, with the latest figure at $2.4 billion in Q2 2026.

• On a quarterly basis, Invested Capital fell 2.26% year-over-year to $2.4 billion in Q2 2026; TTM through Jun 2026 was $2.4 billion, a 2.26% decrease from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 3.62% from the prior year.
• Invested Capital was $2.4 billion for Q2 2026 at Idexx Laboratories, up from $2.4 billion in the prior quarter.
• The five-year high for Invested Capital was $2.5 billion in Q2 2025, with the low at $1.6 billion in Q4 2022.
• Average Invested Capital over 5 years is $2.2 billion, with a median of $2.3 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Invested Capital soared 51.79% in 2023, then slipped 9.11% in 2025.
• Over 5 years, Invested Capital stood at $1.6 billion in 2022, then surged by 51.79% to $2.4 billion in 2023, then slipped by 2.64% to $2.3 billion in 2024, then climbed by 3.62% to $2.4 billion in 2025, then gained by 2.24% to $2.4 billion in 2026.
• The last three Invested Capital figures came in at $2.4 billion (Q2 2026), $2.4 billion (Q1 2026), and $2.4 billion (Q4 2025), per Business Quant data.